In an effort to establish the specificity of the thrombopoietin (TPO) effects on murine multipotential progenitors, we tested the effects of soluble TPO receptor (sTPOR; sMpl) on multilineage colony formation that was supported by a combination of TPO and steel factor (SF). Surprisingly, sTPOR did not suppress colony formation from primitive progenitors. This led to the discovery that sTPOR synergizes with SF or Flt3/Flk2 ligand (FL) to support the formation of various types of hematopoietic colonies including multilineage colonies. The colonies supported by the combination of sTPOR and SF were capable of expressing both myeloid and B-lymphoid potentials. Studies using micromanipulation and serum-free culture showed that the effects of ECENTLY SEVERAL laboratories have cloned the R gene for Mpl ligand, and showed that Mpl ligand is the physiological regulator of thrombopoiesis and is identical to thrombopoietin (TP0j.'-6 Independent from the search for Mpl ligand, we (T.K. and H.M.) purified TPO from the plasma of more than 1,000 thrombocytopenic rats by use of multistep chromatographic procedures and characterized its partial amino acid ~equences.',~ When rat TPO cDNA was cloned its sequence indicated identity of TPO with Mpl ligand. The recombinant TPO proved to possess major thrombopoietic and megakaryocytopoietic activities both in vitro and in V~V O . * ,~,~-"
In an effort to establish the specificity of the thrombopoietin (TPO) effects on murine multipotential progenitors, we tested the effects of soluble TPO receptor (sTPOR; sMpl) on multilineage colony formation that was supported by a combination of TPO and steel factor (SF). Surprisingly, sTPOR did not suppress colony formation from primitive progenitors. This led to the discovery that sTPOR synergizes with SF or Flt3/Flk2 ligand (FL) to support the formation of various types of hematopoietic colonies including multilineage colonies. The colonies supported by the combination of sTPOR and SF were capable of expressing both myeloid and B-lymphoid potentials. Studies using micromanipulation and serum-free culture showed that the effects of ECENTLY SEVERAL laboratories have cloned the R gene for Mpl ligand, and showed that Mpl ligand is the physiological regulator of thrombopoiesis and is identical to thrombopoietin (TP0j.'-6 Independent from the search for Mpl ligand, we (T.K. and H.M.) purified TPO from the plasma of more than 1,000 thrombocytopenic rats by use of multistep chromatographic procedures and characterized its partial amino acid ~equences.',~ When rat TPO cDNA was cloned its sequence indicated identity of TPO with Mpl ligand. The recombinant TPO proved to possess major thrombopoietic and megakaryocytopoietic activities both in vitro and in V~V O . * ,~,~-"
More recently we have observed that TPO can support formation of multilineage colonies from marrow cells of 5-fluorouracil (5-FU)-treated mice in synergy with steel factor (SF, Kit ligand) or interleukin-3 (1L-3).l2 This observation is in agreement with that of Alexander et all' that Mpl knockout mice have reduced number of multipotential progenitors relative to wild-type mice.
In an effort to establish the specificity of the TPO effects on the multipotential progenitors, we tested the effects of sTPOR and SF on the primitive progenitors are direct, not mediated by contaminating stromal cells, and not dependent on factors present in the serum. TPOR belongs to the cytokine receptor group that includes granulocyte colonystimulating factor receptor (G-CSFR) and erythropoietin receptor (EPOR). Therefore, we tested the effects of sG-CSFR and sEPOR on primitive progenitors. sG-CSFR, but not sEPOR, was able to synergire with SF or FL in supporting the proliferation of primitive progenitors. The direct effects of the soluble receptors appear to be mediated through interactions with their respective membrane-bound receptors expressed on the primitive hematopoietic progenitors.
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soluble TPO receptor (sTPORj on multilineage colony formation supported by the combination of TPO and SF. We were surprised to learn that sTPOR does not suppress colony formation from primitive progenitors. This led to the discovery that sTPOR, in synergy with SF or Flt3/Flk2 ligand (FL), can directly stimulate colony formation from primitive progenitors. Studies of soluble receptors for two additional cytokines, ie, soluble granulocyte colony-stimulating factor receptor (sG-CSFR) and soluble erythropoietin receptor (sEPOR), showed that sG-CSFR can also synergize with SF or FL to support colony formation from primitive progenitors. Although the possible physiological roles of soluble receptors for these early acting cytokines need to be established, these observations may be important for in vitro manipulation of hematopoietic stem cells.
MATERIALS AND METHODS
Soluble receptors and cytokines. The recombinant extracellular domain of murine Mpl was purified from the culture supematant of Chinese hamster ovary (CHO) cells according to the method of Bartley et a1.h The murine sG-CSFR, which corresponds to its cytolune homologous region (indicated as BN-BC domain), was prepared using an insect-baculovirus secretion system as de~cribed.'~ The human sEPOR polypeptide was prepared as previously de~cribed.'~ The human sEPOR binds radiolabeled EPO and inhibits the growth of an EPO-dependent cell line (A.D. D' Andrea, unpublished observation). Purified human recombinant TPO was prepared by the TPO Production Group, Kirin Brewery, Co, Ltd. Recombinant murine FL was produced in yeast and purified as previously described." Purified recombinant murine SF was obtained from Immunex corporation (Seattle, WA). Purified recombinant murine IL-3 was purchased from R&D systems (Minneapolis, MN). Purified recombinant human IL-6 was a gift from M. Naruto of Toray Industries Inc (Kamakura, Japan). Purified recombinant human IL-7 was provided by C. Faltynek of Sterling Winthrop Inc (Collegeville, PA). Purified recombinant human IL-11 was a gift from P. Schendel of Genetics Institute (Cambridge, MA). Purified recombinant human EPO was provided by the Genetics Institute Clinical Manufacturing Group (Cambridge, MA). Unless otherwise specified, the concentrations of soluble receptors and cytokines used were as follows: sTPOR, 5 pg/mL; sG- CSFR, 5 pg/mL; sEPOR, 5 pg/mL; TPO, 200 ng/mL; SF, 100 ng/ mL; FL, 1 pg/mL; IL-3, 100 ng/mL,; IL-6, 100 ng/mL; IL-11, 100 ng/mL; IL-7, 200 U/mL; EPO, 2 U/mL.
Hybridoma D7 (anti-Ly-6A.21 E.l, rat immunoglobin G [IgG]2a) was a gift from P. Kincade of Oklahoma Medical Research Foundation (Oklahoma City, OK). MoAbs ACK4 (anti-Kit; rat IgG2a) were provided by S A . Nishikawa of Kyoto University (Kyoto, Japan). Hybridoma RB6-8C5 (anti-mouse granulocytes; rat IgG2b) was provided by R.L. Coffman of DNAX (Palo Alto, CA). MoAb TER119 (anti-erythrocytes; rat IgG2b) was a gift from T. Kina of Kyoto University. Hybridomas 14.8 (anti-B220 rat IgG2b), Mln0.15.11.5 (anti-macrophages; rat IgG2b). GK1.5 (anti-CD4; rat IgG2b), and 53-6.72 (anti-CD8; rat IgG2a) were purchased from American Type Culture Collection (Rockville, MD).
Crude marrow cells obtained from normal All experiments except for those using TPO and one micromanipulation experiment were performed in serum-containing culture. One milliliter of culture mixture contained a-medium (ICN Biomedicals, Aurora, OH), 1.2% 1,500 cp methylcellulose (Shinetsu Chemical, Tokyo, Japan), 0.1 mmoVL 2-mercaptoethanol (2-ME; Sigma Chemical, St Louis, MO), 1% deionized fraction V bovine serum albumin (BSA; Sigma), 30% fetal calf serum (FCS; Intergen, Purchase, NY), and designated soluble receptors or cytokines. Dishes were incubated in a humidified atmosphere with 5% C 0 2 in air. The studies of TPO-induced megakaryocyte colony formation and TPO-induced proliferation of primitive progenitors were performed in serum-free culture because of possible inhibition of colony formation by FCS.I9 In serum-free culture, fraction V BSA and FCS were replaced by a combination of 1% deionized crystallized BSA (Sigma), 600 pg/mL fully iron-saturated human transferrin (>98% pure) (Sigma), 10 pg/mL soybean lecithin (Sigma), 6 pg/mL cholesterol (Sigma), and 1 X lo-' m o m sodium selenite (Sigma). Dishes were incubated in a humidified 5% COz/ 5% 02/90% N2 atmosphere. Colonies consisting of 50 or more cells were scored on an inverted microscope after 14 days of culture, except that the megakaryocyte colonies shown in Fig 1 were scored on day 5. Megakaryocyte colonies were scored when the colony contained 4 or more megakaryocytes. Abbreviations for colony types are as follows: GM, granulocyte/macrophage colonies; GEMM, granulocyte/erythrocyte/macrophage/megak~~y~ colonies; GMM, granulocyte/macrophage/megakaryocyte colonies"; GEM, granulocyte/erythrocyte/macrophage colonies"; Meg, megakaryocyte colonies; BFU-E, erythroid burst, and Blast, blast cell colonies."
Single-cell micromanipulation. One thousand Lin-Ly-6N E+Kit+ cells from the marrow of 5-FU-treated mice were plated in a dish. The dish was gently swirled so that cells were separated from each other. Cells were then lifted individually from the dish with a fine capillary tube attached to a micromanipulator (Hacker Instruments, Inc, Fairfield, NJ) under direct microscopic visualization," and were transferred to serum-containing or serum-free methylcellulose culture containing sTPOR, SF, and EPO. Colonies were examined after 14 days of culture.
The protocols for the analysis of murine lymphohematopoietic progenitors were as described elsewhere." One hundred fifty Lin-Ly-bA/ E+Kit+ cells from the marrow of 5-FU-treated mice were plated per dish in methylcellulose medium containing various cytokine combinations. On days 9, 12, and 15 of the incubation, 20 colonies were picked, pooled, and washed. Five percent of the total cells was plated in the secondary lymphoid methylcellulose culture medium containing SF and IL-7. Pre-B-cell colonies were scored after 10 to 11 days of incubation.
Individual colonies were obtained with an Eppendorf pipette under direct microscopic visualization and suspended in 0.2 mL of phosphate-buffered saline containing 50% FCS. Cells were then spun in a Cytospin I1 (Shandon Southern, Sewickley, PA) at 750 rpm for 5 minutes and processed for May-Griinwald-Giemsa staining.
Clonal cell culture.
Analysis of lymphoid potentials of progenitors in culture.
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RESULTS
Inhibition of megakaryocyte colony formation from mar-
Murine sTPOR has been shown row cells of normal mice.
For personal use only. on October 27, 2017. by guest www.bloodjournal.org From to block the effects of TPO on murine megakaryocyte colony formation. 24 We have reported previously that murine sTPOR partially blocks the stimulatory effects of human TPO on EPO-dependent erythroid proliferation in culture.'' First we confirmed the negative effects of murine sTPOR on megakaryocyte proliferation. We tested megakaryocyte colony formation from 1.5 X 10' marrow cells of normal mice supported by varying concentrations of TPO in the presence and absence of sTPOR. As shown in Fig I , there was dose-dependent stimulation of megakaryocyte colony formation by TPO. Addition of 5 pg/mL sTPOR to TPOcontaining cultures significantly decreased the number of megakaryocyte colonies. These data, together with the observation of inhibition of human erythroid proliferation by sTPOR," suggest that sTPOR inhibits proliferation of committed progenitors. In contrast, the results presented in Table  1 suggest that the effects of sTPOR on primitive progenitors are very different. Table 1 . In this experiment we plated 150 enriched marrow cells of 5-FU-treated mice in the presence of 2 U/mL EPO and designated cytokines. A combination of sTPOR and SF supported colony formation including formation of multilineage colonies that was equal to that supported by a combination of TPO and SF. Addition of sTPOR to the combination of TPO and SF did not suppress colony formation. In general, the multilineage colonies supported by sTPOR and SF were large, containing 7.5 X lo4 to 29.4 X IO4 cells per colony. Photomicrographs of a representative multilineage colony in situ and a cytocentrifuge preparation of individual cells are shown in Figs 2A and 2B , respectively. A study of dose-effects of sTPOR, performed in the presence of SF and EPO, showed the plateau concentration of 5 pg/mL sTPOR (Fig 3) .
Stimulatory effects
The direct nature of the effects of sTPOR was demonstrated by plating individual micromanipulated enriched progenitors in culture as described previously." First, the enriched marrow cells from 5-W-treated mice were plated in methylcellulose. By using a Hacker micromanipulator, progenitors were individually lifted and plated in culture containing sTPOR, SF, and EPO. As shown in Table 2 , a total of 98 micromanipulated cells produced 51 colonies including 21 multilineage colonies in serum-containing culture. In serum-free culture, a total of 98 micromanipulated cells produced 18 colonies including 4 multilineage colonies. These results unequivocally established that the effects of these cytokines are direct, not mediated by cytokines produced by contaminating stromal cells and not dependent on factors present in the serum.
Lineage expression by the progenitors supported by the combination of sTPOR and SF was analyzed by detailed cytological examination of the colonies. In this experiment. 50 enriched marrow cells were plated per dish in the presence of sTPOR, SF, and EPO, and on day 14 of incubation all resulting colonies were individually lifted from methylcellulose culture and processed for cytological analysis by use of a Shandon type I1 cytocentrifuge. As shown in Table 3 , all myeloid lineages except for eosinophil lineage were expressed in culture while individual multilineage colonies differed significantly in their content of myeloid lineages.
L~tnphohematopoietic potentinls ofthe colonies supported by the Combination of sTPOR and SF. A few years ago we described a two-step methylcellulose culture assay for identification of murine lymphohematopoietic progenitors that are capable of expressing myeloid and B-lymphoid line a g e~.~~ When growth factor requirements of the lymphohematopoietic progenitors were studied, combinations of SF with either IL-11, IL-6, granulocyte colony-stimulating factor (G-CSF), or IL-12, were found to effectively support the B-cell potential of the primary c~l o n i e s .~~~*~ Therefore, we tested whether the colonies supported by the combination of sTPOR and SF possess B-cell potential. One hundred fifty enriched cells were plated in the presence of either a combination of sTPOR, SF, and EPO or a combination of IL-11, SF, and EPO. In a parallel experiment, IL-7 was added to the cytokine combinations to test whether or not it is required in the primary culture. On days 9, 12, and 15 of incubation, 20 colonies were randomly picked from each experimental group, and the cells were pooled and washed. Aliquots of the cells were then plated in the secondary dishes containing IL-7 and SF to allow the pre-B-cell colonies to develop. Lin-Ly-6NE' Kit+ cells prepared from the marrow of 5-FU-treated mice were individually plated in culture in the presence of 5 pg/mL sTPOR, 100 ng/mL SF, and 2 U/mL EPO. Dishes were examined on day 14 of culture. Although time-courses somewhat differed between the two cytokine groups, the results presented in Table 4 indicated that sTPOR in the presence of SF and EPO is capable of supporting formation of lymphohematopoietic colonies with B-cell potential. A definitive demonstration of the lymphohematopoietic nature of the colonies supported by the combination of sTPOR, SF, and EPO was made again by using micromanipulation of individual cells. A total of 49 micromanipulated cells produced 23 colonies in cultures containing sTPOR, SF, and EPO on day 12. An aliquot of cells from individual colonies was then processed for suspension culture containing IL-3, SF, IL-6, and EPO, and cytological analysis of myeloid lineages. Cells were also plated in secondary cultures containing SF and IL-7 for analysis of B-cell potential. Of the 23 primary colonies, 2 produced multiple myeloid lineages and pro-B cells (data not shown). This result clearly showed that the targets of sTPOR include lymphohematopoietic progenitors.
Effects of sTPOR and other early-acting cytokines. Next, we examined possible synergy between sTPOR and other early acting cytokines. The enriched marrow cells prepared from 5-FU-treated mice were plated in the presence of single cytokines or a combination of early acting cytokines. We chose IL-3, IL-6, and FL as additional representative cytokines belonging to the three functional groups described previously.z6 Results of day 14 colony formation are shown in Table 5 . sTPOR interacted with SF or FL but not with IL-3 or IL-6 in triggering the proliferation of primitive hematopoietic progenitors.
Colonies identified in cultures containing FL were immature on day 14 of incubation as demonstrated previ~usly.~~ To test the lineage potentials of the immature colonies, we replated the colonies individually on day 12 of incubation into suspension cultures containing IL-3, SF, IL-6, and EPO.
For personal use only. on October 27, 2017. by guest www.bloodjournal.org From 150 Lin-Ly-6NE' Kit+ cells prepared from the marrow of 5-FU-treated mice were plated per dish. The number of pre-B-cell colonies was derived from 5% of 20 pooled colonies. Data represent the mean or the mean t standard deviation. Concentration of cytokines are: sTPOR, 5 pg/mL; SF, 100 ng/mL; IL-11, 100 ng/mL; IL-7, 200 U/mL; EPO 2 U/mL.
Serial cytological analyses revealed differentiation into macrophages andor neutrophils. TPOR belongs to the cytokine receptor group that includes G-CSFR and EPOR.28 Therefore, in the next experiments we tested the possible effects of sG-CSFR and sEPOR on primitive progenitors. Fifty enriched cells prepared from the BM of 5-FU-treated mice were cultured in the presence of EPO and either a single early acting cytokine or combinations of early acting cytokines. The results are presented in Table 6 . Similar to the results in Table 5 , none of the cytokines except IL-3 supported colony formation effectively as a single factor. However, sG-CSFR and SF showed distinct synergy in support of colony formation including multilineage colony formation. There was a weak synergy between sG-CSFR and FL. We tested the lineage potentials of the immature colonies supported by the combination of sG-CSFR and FL by replating into cultures containing IL-3, IL-6, SF, and EPO. Again, Studies of sG-CSFR and sEPOR.
the majority of the colonies yielded macrophages whereas some produced macrophages and neutrophils. sG-CSFR did not synergize with IL-3. sEPOR showed no synergy with the cytokines tested. All cultures contained 2 U/mL EPO. To rule out possible interaction between EPO and sEPOR, we examined the effects of sEPOR again in the absence of EPO on enriched cells. There were no differences in the cell number between cultures containing sEPOR and SF and those containing SF alone after 14 days of incubation (data not shown).
DISCUSSION
In normal steady state, hematopoietic stem cells and primitive progenitors are in the cell cycle-quiescent state called Go. 29 There is now experimental evidence that the quiescent cells require interaction with more than one cytokine to initiate cell cycling. In a recent reviewz6 we described a model of cytokine interactions regulating primitive progenitors based 150 Lin-Ly-WE' Kit+ cells prepared from the marrow of 5-FU-treated mice were cultured in the presence of 2 U/mL EPO and designated cytokines. Dishes were examined on day 14 of culture. Data represent the mean and standard deviation of values obtained from four dishes.
Concentration of cytokines are: sTPOR, 5 pg/mL; SF, 100 mg/mL; FL, 1 pg/mL; IL-6, 100 ng/mL; IL-3, 100 ng/mL. * In situ diagnosis was not done since many cells in individual colonies were immature." t 50 Lin-Ly-6NE' Kit+ cells were plated per dish.
For personal use only. on October 27, 2017. by guest www.bloodjournal.org From primarily on cell culture investigations performed in our laboratory. In this model the early acting cytokines are arbitrarily divided into three functional groups. SF2s,30,31 and FLZ7 are both ligands for receptors with tyrosine kinase activity and show significant functional overlap. IL-3,32 IL-4,33 and granulocyte-macrophage colony-stimulating factor (GM-CSF)34.3s form the second group of cytokines. The individual cytokines in this group have been shown to support proliferation of multipotential and monopotential progenitors that are in the cell cycle. The third group consists of IL-6,96 IL-11 , 37 IL-12,2s338 G-CSF,39 and leukemia inhibitory factor@ and appear to be related to each other through homology of cytokines or their respective receptors.26 Most recently we showed that TPO can function as a member of the third group." For effective stimulation of cycling of the dormant progenitors, a combination of cytokines each belonging to a different functional group is necessary.
Using a clonal cell culture method, we have shown that the soluble forms of TPO receptor and G-CSF receptor also synergize with SF or FL in supporting the proliferation of murine primitive hematopoietic progenitors. The progenitors in the marrow of 5-FU-treated mice were enriched by a combination of density gradient centrifugation, immunomagnetic depletion of mature, committed cells and FACS-sorting for Ly-6A/E+ Kit+ cells. This purification protocol results in a cell population that is highly enriched for dormant primitive hematopoietic progenitors, including long-term reconstituting cells. 41 We showed, by serum-free culture of micromanipulated individual progenitors, that the effects of sTPOR and SF are direct and are not mediated by other cells or factors present in the serum. Cytological analysis confirmed the multilineage nature of the colonies. The fact that a combination of sTPOR, SF, and EPO can preserve the B-cell potential of the primitive population suggests that sTPOR acts on the cells at a very early stage of hematopoiesis, possibly hematopoietic stem cells. The synergies between SF and soluble receptors were stronger than those involving FL. This observation is in agreement with our previous ~bservation~~ that SF supports formation of more colonies than FL, when combined with either IL-6, IL-11, or G-CSF.
The current understanding of the mechanisms of soluble receptors includes their role as inhibitors of their respective membrane-bound receptors by competing for the ligands, downregulators of the expression of membrane-bound receptors, stabilizing proteins of ligands, and participants of ligand-induced signaling. 42 In this report, we have shown that sTPOR is able to inhibit ligand-dependent megakaryocyte colony formation from the marrow cells of normal mice, an activity that had been described by others." Earlier, we demonstrated that sTPOR counteracts TPO in its enhancement of human erythroid proliferation." However, the same soluble receptor showed a direct, positive stimulation of the proliferation of primitive progenitors. The structure similarities between sTPOR, sG-CSFR, and sEPORZ8 prompted us to examine sG-CSFR and sEPOR for the possible stimulatory effects on primitive progenitors. We found that sG-CSFR, but not sEPOR, can synergize with SF or FL in supporting the proliferation of primitive progenitors. Both TPOL2 and G-CSF3L339 have been shown to support proliferation of primitive progenitors of mice in synergy with SF or IL-3. Studies of EPO-null mice clearly demonstrated that EPO does not It was reported recently that soluble IL-6 receptor (sIL-6R), IL-6, and SF synergize to stimulate proliferation of human primitive hematopoietic progenitor^.^^ It was proposed that sIL-6WL-6 complex initiates signal transduction through gp 130, a signal-transducing component of IL-6R. Unlike s I L -~R , the effects of sTPOR do not appear to require the presence of exogenous TPO or signal-transducing protein gp 1 30.45 It is possible that primitive progenitors express TPO and G-CSF on the cell surface and these ligands interact with their respective soluble receptors. In support of this concept are the observations that primitive hematopoietic cells can express several cytokines including transforming growth factor-,!?:' IL-l,!?,47 IL-3, GM-CSF:* SF, and FL.4y The molecular mechanisms of sTPOR and sG-CSFR to induce a proliferative signal in primitive progenitors await further elucidation. At the moment we are not certain of the physiologic implications of our observations. It is generally held that cell-cycle dormant primitive progenitors reside in close contact with stromal cells whereas actively dividing maturer cells are less adherent to stromal It is possible that the apparent bi-directional effects of sTPOR somehow reflect the differences in the physical proximity of the stromal cells producing cytokines and the progenitors at different stages of development. Regardless, the observed positive effects of the soluble receptors for early acting cytokines on primitive progenitors may have implications in stem cell manipulation in vitro.
